Armata Pharmaceuticals Analyst Ratings
Armata Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 44.63% | HC Wainwright & Co. | $7 → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/17/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 03/07/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 03/22/2021 | 44.63% | HC Wainwright & Co. | $5 → $7 | Maintains | Buy |
| 05/15/2020 | 3.31% | HC Wainwright & Co. | $9 → $5 | Reiterates | → Buy |
| 03/20/2020 | 85.95% | HC Wainwright & Co. | $9.5 → $9 | Reiterates | → Buy |
| 02/06/2020 | 65.29% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 06/19/2019 | 85.95% | Ladenburg Thalmann | → $9 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 44.63% | HC Wainwright公司 | $7→$7 | 重申 | 購買→購買 |
| 2023年05月12日 | 44.63% | HC Wainwright公司 | →$7 | 重申 | 購買→購買 |
| 03/17/2023 | 44.63% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 03/07/2023 | 44.63% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 03/22/2021 | 44.63% | HC Wainwright公司 | $5→$7 | 維護 | 買 |
| 2020/05/15 | 3.31% | HC Wainwright公司 | $9→$5 | 重申 | →購買 |
| 03/20/2020 | 85.95% | HC Wainwright公司 | $9.5→$9 | 重申 | →購買 |
| 02/06/2020 | 65.29% | Maxim集團 | →$8 | 開始承保 | →購買 |
| 2019年6月19日 | 85.95% | 拉登堡·塔爾曼 | →$9 | 開始承保 | →購買 |
What is the target price for Armata Pharmaceuticals (ARMP)?
Armata PharmPharmticals(ARMP)的目標價是多少？
The latest price target for Armata Pharmaceuticals (AMEX: ARMP) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $7.00 expecting ARMP to rise to within 12 months (a possible 44.63% upside). 4 analyst firms have reported ratings in the last year.
2023年8月14日，HC Wainwright&Co.報道了Armata製藥公司(美國證券交易所代碼：ARMP)的最新目標價。這家分析公司將目標價定為7.00美元，預計ARMP將在12個月內上漲至44.63%。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Armata Pharmaceuticals (ARMP)?
分析師對Armata製藥公司(ARMP)的最新評級是多少？
The latest analyst rating for Armata Pharmaceuticals (AMEX: ARMP) was provided by HC Wainwright & Co., and Armata Pharmaceuticals reiterated their buy rating.
分析師對Armata製藥公司(美國證券交易所代碼：ARMP)的最新評級是由HC Wainwright&Co.提供的，Armata製藥公司重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Armata Pharmaceuticals (ARMP)?
Armata PharmPharmticals(ARMP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Armata Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Armata Pharmaceuticals was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Armata製藥公司的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Armata製藥的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右的某個時候公佈。
Is the Analyst Rating Armata Pharmaceuticals (ARMP) correct?
分析師對Armata PharmPharmticals(ARMP)的評級正確嗎？
While ratings are subjective and will change, the latest Armata Pharmaceuticals (ARMP) rating was a reiterated with a price target of $7.00 to $7.00. The current price Armata Pharmaceuticals (ARMP) is trading at is $4.84, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Armata製藥(ARMP)評級被重申，目標價在7.00美元至7.00美元之間。Armata PharmPharmticals(ARMP)目前的交易價格為4.84美元，超出了分析師的預測區間。